Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03450967 |
|---|---|
| Brief Title: | Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC |
| First Submitted : | February 23, 2018 |
| First Submitted that Met QC Criteria : | February 23, 2018 |
| First Posted : | March 1, 2018 |
| Last Update Submitted that Met QC Criteria : | August 8, 2021 |
| Last Update Posted : | August 10, 2021 |